Kann sich noch jemand an diesen Teil des Q3 2023 erinnern? Got it. September 2023, the Company received €2.9 million for Gohibic (vilobelimab) product shipments from a subsidiary of Cencora which …
Kann sich noch jemand an diesen Teil des Q3 2023 erinnern? Got it. September 2023, the Company received €2.9 million for Gohibic (vilobelimab) product shipments from a subsidiary of Cencora which …